Clinical Trial

Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma

Study acronym: FLASH
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Open label, randomized, controlled phase II study preceded by a safety run-in part in subjects with advanced or metastatic soft-tissue sarcoma.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-01-28; most recent amendment 2025-01-23.
Status change: Recruiting → Active, Not Recruiting 2025-01-23
Trial Details
NCT Number NCT04733183
Lead Sponsor Philogen S.p.A.
Conditions Soft Tissue Sarcoma
Enrollment 98 participants
Start Date 2020-08-28
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-27